Glam girl Heddy Lamar may have used her good looks to good effect on the silver screen, but she put her smarts to better use as an inventor. During World War II, she co-patented a frequency-switching system for torpedo guidance that was considered years ahead of its time.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7365089 | Triazolo-quinolin derivatives useful as adenosine receptor ligands The present invention relates to adenosine A3? receptor ligands of the general formula (I), within those preferably antagonists, as well as their salts, solvates and isomers, and the pharmaceutical compositions containing them, to the use of the compounds of the gen... | 04/29/2008 |
| 7176213 | Imidazoquinoline derivatives and their use as adenosine A3 ligands The present invention relates to adenosine A3 receptor ligands of the general formula (I), within those preferably antagonists, as well as their salts, solvates and isomers, and the pharmaceutical compositions containings them, to the use of the compounds... | 02/13/2007 |
| 6916838 | 1-benzylpyrazole-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists Tricyclic derivatives of 1-benzylpyrazole-3-carboxylic acid which are antagonists of the cannabinoid CB2 receptors; their method of preparation and pharmaceutical compositions containing them. ... | 07/12/2005 |
| 6908927 | Pyridopyranoazepine derivatives, their preparation and their therapeutic application The invention relates to pyridopyranoazepine derivatives, to pharmaceutical compositions containing them, to process for preparing them, and to the method of use thereof in the treatment or prevention of disorders associated with a dysfunction of the nicotine recept... | 06/21/2005 |
| 6893659 | Pharmaceutical composition for oral administration of a N-piperidino-3- pyrazolecarboxamide derivative, its salts and their solvates The pharmaceutical compositions for oral administration according to the invention contain 0.5% to 20% of N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide in microcrystalline form, and pharmaceutical excipients; they are formulat... | 05/17/2005 |
| 6894186 | Hydroxyacetic ester derivatives, preparation method and use as synthesis intermediates Methyl (R)-2-(R1OSO2)-2-(2-chlorophenyl)acetates useful as intermediates in the preparation of methyl (S)-2(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno[3,2-c]-5-pyridyl)acetate. ... | 05/17/2005 |
| 6884895 | Process for the preparation of spiro[(4-cyclohexanone)-[3]indol]-2′[1′H]-one derivatives The invention relates to a process for the preparation of spiro[(4-cyclohexanone)-[3H]indol]-2′[1′H]-one derivatives of the general formula I wherein R1 and R2 independently stand for hydrogen... | 04/26/2005 |
| 6867220 | Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them The invention relates to compounds of formula (I) where R1 represents a hydrogen or halogen atom or an —S(O)z—(C1-C4)alkyl, —S(O)z—(C1 | 03/15/2005 |
| 6864277 | 1,3-dihydro-2H-indol-2-one derivatives, method for preparing same and pharmaceutical compositions containing them The invention relates to compounds of formula: and to solvates and/or hydrates thereof, with affinity for and selectivity towards the Vreceptors or both the V1b and V1a receptors of arginine-vasop... | 03/08/2005 |
| 6861072 | Pharmaceutical composition with gastric residence and controlled release The invention concerns a pharmaceutical composition with gastric residence and controlled release, characterized in that it comprises two or three layers and contains (a) an active principle associated with a excipient modifying its release; (b) a system generating ... | 03/01/2005 |
| 6858629 | Heteroaryloxy propanolamines, preparation method and pharmaceutical compositions containing same Compounds of formula (I): where X is N or CH; A represents a group of formula (a) or (b) R1 represents hydrogen or an —NH2, —NR... | 02/22/2005 |
| 6852736 | Phenoxypropanolamines, preparation and therapeutic use thereof The invention concerns phenoxypropanolamines of formula (I) in which R1 represents a hydrogen, a group —S(O)z—(C1-C4)alk-R′, (R′ being H, phenyl or (C1-C | 02/08/2005 |
| 6846936 | 2-butyl-3-(4-[3(dibutylamino)propoxy]benzoyl)-5-nitro-benzofuran hydrochloride and preparation thereof The invention relates to 2-butyl-3-(4-[3-(dibutylamino)propoxy]benzoyl-5-nitrobenzofuran hydrochloride, to its preparation and to its use as synthetic intermediate, in particular in preparing 2-butyl-3-(4-[3-(dibutylamino)propoxy]benzoyl)-5-nitrobenzofuran, itself a... | 01/25/2005 |
| 6844335 | 2-amino-3-(alkyl)-pyrimidone derivatives as GSK3.β.inhibitors A pyrimidone derivative represented by formula (I) or a salt thereof: Wherein: R1 represents a hydrogen atom or a C1-6 alkyl group which may be substituted by a C | 01/18/2005 |
| 6844329 | Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative The present invention relates to novel synthetic polysaccharides with antithrombotic activity exhibiting at least one covalent bond with biotin or a biotin derivative and to a process employing avidin or streptavidin which makes it possible to neutralize these polys... | 01/18/2005 |
| 6844337 | 1,4-diazabicyclo[3.2.2]nonane-phenylisoxazole derivatives, their preparation and their application in therapeutics Compounds corresponding to general formula (I) in which R1, R2, R3, R4 and R5 each represent, independently of one another, a hydrogen or halogen atom or a nitro, ... | 01/18/2005 |
| 6835730 | 4-heteroparyl-1,4-diazabicyclo[3.2.2]nonane, preparation and therapeutic use thereof Compounds of the general formula (I) in which R1, R2, R3 and R4 each represent a hydrogen or halogen atom or a nitro, amino, trifluoromethyl, cyano, hydroxyl, alkyl or alkoxy... | 12/28/2004 |
| 6828448 | Methanesulphonamido-benzofuran, preparation method and use thereof as synthesis intermediate The invention relates to 2-butyl-5-(methanesulfonamido)benzofuran, its preparation and its use. This compound is a synthesis intermediate, in particular for the preparation of dronedarone. ... | 12/07/2004 |
| 6828321 | 1,2,4-Benzotriazine oxides as radiosensitizers and selective cytotoxic agents A method of using 1,2,4-benzotriazine oxides, some of which are novel compounds, as radiosensitizers and selective cytotoxic agents is disclosed. These compounds are shown to specifically radiosensitize hypoxic tumor cells. Some are additionally disclosed to be usef... | 12/07/2004 |
| 6806282 | Branched substituted amino derivatives of 3-amino-1-phenyl-1h-[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them The present invention relates to novel branched substituted amino derivatives of 3-amino-1-phenyl-1H-[1,2,4]triazole, processes for their preparation and pharmaceutical compositions comprising them. ... | 10/19/2004 |
| 6800761 | Form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same The invention relates to a novel crystalline form of irbesartan, to pharmaceutical compositions containing it, to processes for preparing it, and to a method for treating cardiovascular diseases utilizing it. ... | 10/05/2004 |
| 6794382 | Benzimidazole derivatives, preparation and therapeutic use thereof The invention relates to benzimidazole derivatives of general formula in which X represents a nitrogen atom or a carbon atom; and when X represents a nitrogen atom: R3 represents a hydrogen atom or a... | 09/21/2004 |
| 6767533 | Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress A composition containing a peripheral benzodiazepine receptor ligand for topical use in the treatment of cutaneous stress. ... | 07/27/2004 |
| 6761879 | Titanium derived compounds, preparation and use thereof The invention relates to a titanium-derived compounds, and to processes for preparing the same. ... | 07/13/2004 |
| 6730695 | 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for V1b and V1a arginine-vasopressin receptors The invention relates to compounds of formula: as well as the possible salts thereof with mineral or organic acids, and the solvates and/or hydrates thereof, which have affinity for and selectivity towards the V1b | 05/04/2004 |
| 6713053 | Use of IL-7 for treating auto-immune diseases and insulin-dependent diabetes mellitus in particular The use of interleukin 7 or T cells pre-incubated in the presence of IL-7 for preparing a drug or pharmaceutical composition for treating an auto-immune disease, particularly an auto-immune disease induced by a defect in CD4+ T cell immunoregulation, is disclosed. | 03/30/2004 |
| 6710042 | Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them Compounds of formula (I) are useful as human NK3 receptor antagonists. ... | 03/23/2004 |
| 6693118 | Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-댡 The invention relates to the use of a compound of formula (I): ##STR1## for the preparation of pharmaceutical compositions for increasing the circulating, cellular and extracellular levels of TGF-댡.... | 02/17/2004 |
| 6689797 | Tetrahydropyridines, preparation method and pharmaceutical compositions containing same The present invention relates to compounds of formula (I): ##STR1## in which R1 represents a hydrogen or halogen atom, or a group CF3 ; R2 and R3 represent, independently, a hydrogen atom or a methyl group; n and n' ... | 02/10/2004 |
| 6680329 | N-(heterocyclyl)benzene or pyridinesulphonamides as antithrombotic agents and anticoagulants Compounds of formula [I] ##STR1## in which: W may represent a --(CH2)2 --, --(CH2)3 --, --CH2 --C.ident.C-- or --CH2 --CH.dbd.CH-- group, R2 may in particular represent a pipe... | 01/20/2004 |
| 6670486 | Process for racemization The invention relates to the racemisation process of the optically active [2-(2-thienyl)ethylamino](2-halogenophenyl)acetamides of general formula (VII) by using basic compounds. The resulting racemic compounds of general formula (VII) can thus be recycle... | 12/30/2003 |
| 6670338 | Pentasaccharides processes for their preparation and pharmaceutical compositions containing them Pentasaccharides in acidic form and their pharmaceutically acceptable salts, the anionic form thereof having the formula: ##STR1## wherein: R represents hydrogen or an --SO3-, (C1 -C3)alkyl or (C2... | 12/30/2003 |
| 6649627 | Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same The invention concerns compounds of formula (Ia) ##STR1## wherein R1a represents hydrogen, an --S(O)z --(C1 -C4)Alk group, a --CO(C1 -C4)Alk group, an --NHSO2 --(C1 ... | 11/18/2003 |
| 6642233 | 1-Phenacyl-3-phenyl-3-(piperidylethyl)piperidine derivatives, process for the preparation thereof and pharmaceutical compositions containing them The invention relates to the compounds of formula: ##STR1## as well as to the salts thereof with inorganic or organic acids, to solvates thereof and/or to hydrates thereof, which have strong affinity and high selectivity for the human NK1 recep... | 11/04/2003 |
| 6642258 | Use of central cannabinoid receptor antagonist for preparing medicines The invention relates to the use of a central cannabinoid receptor antagonist for the preparation of medicinal products that are useful in treating and preventing neuroinflammatory pathologies.... | 11/04/2003 |
| 6639083 | Method for preparing a thiopene derivative The invention relates to a process for preparing 2-thienyl-2-ethanol, in which: a) thiophene is metallated using an alkali metal, in the presence of an electron transfer agent, b) the compound obtained is treated with ethylene oxide, c) the thienyl... | 10/28/2003 |
| 6635645 | 2,5,-diazabicyclo[2.2.1]heptane derivatives, their preparation and therapeutic uses The invention relates to 2,5-diazabicyclo[2.2.1]heptane derivatives, to pharmaceutical compositions containing them, and to methods for the treatment or prevention of disorders associated with a dysfunction of the nicotinic receptors utilizing them.... | 10/21/2003 |
| 6627649 | Pharmaceutical compositions containing in combination two antagonists selective of arginine-vassopressin V receptors, even of V1 a and V2 receptors The invention relates to pharmaceutical compositions containing (2S)-1-{(2R,3S)-5-chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxybenzenesulfony l)-3-hydroxy-2,3-dihydro-1H-indole-2-carbonyl}pyrrolidine-2-carboxamide, a selective V1a arginine vasopres... | 09/30/2003 |
| 6624164 | 1,3-dihydro-2H-indol-2-one derivatives, preparation method and pharmaceutical composition containing them The invention relates to compounds of formula: ##STR1## and their solvates and/or hydrates exhibiting affinity for the arginine-vasopressin V1b receptors or for both V1b and V1a receptors. The invention also relates to the... | 09/23/2003 |
| 6617336 | 2-arylquinoline derivatives, preparation and therapeutic use thereof Compounds of general formula (I) ##STR1## in which: A represents a hydrogen atom, a hydroxyl, a C1-3 alkoxy group, a hydroxy(C1-6 alkyl) group, a (C1-3 alkoxy)(C1-3 alkyl) group, a thiol, (C1-6 al... | 09/09/2003 |